Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.12 is 142% above its 2-year average of 0.46, near the high end of its 2-year range (0.00–1.12).
As of the fiscal period ended Tuesday, June 30, 2026. 33.37% above its 12-month average of 0.84.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.12.
CURRENT RATIO
1.12
CURRENT RATIO AVG TTM
0.84
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+33.37%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 750 covered companies
CURRENT VS SECTOR MEDIAN
-68.76%
vs the sector median at left
Park Dental Partners, Inc. Common Stock
Market Cap
$93.28M
Current Ratio
1.12
TTM Avg
0.84
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$90.42M
Current Ratio
4.50
TTM Avg
8.19
3Y Avg
12.95
5Y Avg
15.06
Market Cap
$90.13M
Current Ratio
7.70
TTM Avg
11.16
3Y Avg
14.97
5Y Avg
23.58
Market Cap
$97.48M
Current Ratio
8.13
TTM Avg
8.55
3Y Avg
9.73
5Y Avg
13.44
Market Cap
$89.21M
Current Ratio
27.26
TTM Avg
12.68
3Y Avg
13.62
5Y Avg
17.71
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Park Dental Partners, Inc. Common Stock (PARK) | $93.28M | 1.12 | 0.84 | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $93.63M | 3.47 | 4.19 | 5.60 | 16.48 |
| electroCore, Inc. (ECOR)vs › | $91.51M | 1.21 | 1.40 | 1.89 | 3.11 |
| Equillium, Inc. (EQ)vs › | $90.73M | 23.40 | 7.13 | 4.61 | 6.59 |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $90.42M | 4.50 | 8.19 | 12.95 | 15.06 |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $90.13M | 7.70 | 11.16 | 14.97 | 23.58 |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $97.48M | 8.13 | 8.55 | 9.73 | 13.44 |
| ImmuCell Corporation (ICCC)vs › | $89.34M | 4.75 | 3.83 | 3.74 | 4.48 |
| Rallybio Corporation (RLYB)vs › | $89.21M | 27.26 | 12.68 | 13.62 | 17.71 |
| Korro Bio, Inc. (KRRO)vs › | $97.49M | 9.55 | 7.84 | 7.78 | 8.56 |
Current Ratio
1.12
Quick Ratio
1.12
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.12 |
| 2026-03-31 | 1.07 |
| 2025-12-31 | 1.06 |
| 2025-09-30 | 0.52 |
| 2025-06-30 | 0.43 |
| 2025-03-31 | 0.43 |
| 2024-12-31 | 0.00 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 0.00 |
